In patients with head and neck cancer, posttreatment imaging can be complicated and
difficult to interpret because of the complexity of the surgical procedures performed and the …

Background/Aim: Clinical trials with therapies targeting immune checkpoint molecules have
shown promising results in several tumor types. However, the predictive and prognostic …

Objective Peripheral blood–derived inflammation-based scores, such as the neutrophil-lymphocyte
ratio (NLR), platelet-lymphocyte ratio (PLR), and the combination of platelet count …

Although identification of human papilloma virus (HPV) status in oropharyngeal squamous
cell carcinoma (OPSCC) is essential in predicting treatment response, no imaging modality …

Hypopharyngeal squamous cell carcinoma (HPSCC) is an aggressive disease with poor
prognosis; but has no established biomarkers on the order of human papilloma virus and p16 …

Nivolumab, an immune checkpoint inhibitor is the first-line therapy for platinum-resistant
recurrent/metastatic head and neck cancer, and highly effective for some patients. However, no …

Background Factors involved in neck lymph node metastasis (NLM) and prognosis of early
tongue squamous cell carcinoma (SCC) remain unknown. Methods We analyzed disease‐…

OBJECTIVES: The purpose of this study was to assess the value of the apparent diffusion
coefficient (ADC) in the differential diagnosis between benign and malignant thyroid nodules, …

Left vocal cord paralysis in association with patent ductus arteriosus is unusual. We report a
patient with long-standing patent ductus arteriosus (PDA) in whom CT studies obtained …

Aim: Recent studies have demonstrated that netrin-1 plays a vital role in bone metabolism.
Previous studies have shown that osteoblasts produce netrin-1 which affects osteoclast …